Original Research
Published on 08 Oct 2020
A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01329
- 7,996 views
- 20 citations
